Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AFI Partners is a New York-based private equity firm that specializes in control and non-control investments in middle-market companies undergoing significant transitions, such as corporate divestitures, restructurings, and special situations. The firm has a notable focus on the healthcare and life sciences sectors, highlighted by its acquisition of United BioSource (UBC), a leading provider of pharmaceutical support services, risk management, and real-world evidence solutions. AFI Partners also manages investment vehicles such as AFI Partners Fund IV, which has been involved in the health and wellness space, including the distribution of sports nutrition products through Europa Sports Partners. The firm leverages its extensive operational and financial expertise to drive growth and operational improvements across its portfolio. AFI Partners is headquartered in New York City and maintains a diverse investment portfolio across multiple industries including healthcare, manufacturing, and distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AFI Partners Fund IV.